A Phase Ib/II Study of Cetuximab and Pembrolizumab in Metastatic Colorectal Cancer
Phase of Trial: Phase I/II
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Cetuximab (Primary) ; Pembrolizumab (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 15 Aug 2016 Status changed from not yet recruiting to recruiting.
- 19 May 2016 Planned initiation date changed from 1 Apr 2016 to 1 Jun 2016.
- 22 Mar 2016 New trial record